As you progress, the dosage may be adjusted monthly to tailor the program to your evolving needs
This applies to both patients and healthcare professionals and helps the MHRA monitor the ongoing safety of medicines used in the UK
Our customized programs ensure that you receive the right dosage, support, and affordability to make your weight loss journey a success
The situation is also similar in the UK
If you want specific sources to read, check the New England Journal of Medicine trial on GLP1 agents for metabolic outcomes, the 2024 JAMA Internal Medicine paper on semaglutide and mental health, the 2024 Scientific Reports analysis, and recent reviews by regulatory agencies and psychiatry meetings that discuss case reports and signal detection
A consistent dosing schedule will help you achieve the best results: missed doses or inconsistent timing can reduce Wegovys effectiveness